UW

Located in Seattle, Washington, the company specializes in advanced biotechnological solutions, focusing on the development and application of next-generation antibodies and glycoproteomic techniques. Their innovative contributions aim to revolutionize therapeutic methods, particularly in the realms of cancer medicine, autoimmune disorders, and infectious diseases.

By harnessing the complex interactions of glycan and protein systems, the company plays a pivotal role in transforming diagnostics and therapeutic applications within the medical field. Their commitment to pioneering research underscores the significance of glycosylation in biomanufacturing and therapeutic advancements.

Generated from the website